Eli Lilly News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

25.06.18	Boehringer Ingelheim & Eli Lilly: Empagliflozin Trials Meet Primary Endpoint (RTTNews)
25.06.18	Eli Lilly To Present Phase 3 Data For Galcanezumab, Lasmiditan - Quick Facts (RTTNews)
25.06.18	LLY Scores Win In Alimta Patent Suit, LXRX For The Long Haul, MNKD Breathes Easy (RTTNews)
23.06.18	Eli Lilly: Jardiance Reduces Risk Of Kidney Disease Progression In Diabetes (RTTNews)
23.06.18	Eli Lilly: Lispro Shows Improved Blood Sugar Control In Phase 1b Studies (RTTNews)
23.06.18	Eli Lilly: Trulicity Phase 2 Data Shows Efficacy In People With Type 2 Diabetes (RTTNews)
18.06.18	Lilly Declares Third-Quarter 2018 Dividend (PR Newswire)
13.06.18	CAH Closer To FDA Approval, Another Alzheimer's Disease Drug Fails, VTVT Tanks (RTTNews)
12.06.18	AstraZeneca, Eli Lilly To Discontinue Lanabecestat Trials In Alzheimer's (RTTNews)
12.06.18	Update on Phase 3 Clinical Trials of Lanabecestat for Alzheimer's Disease (PR Newswire)
11.06.18	Elanco Animal Health Introduces New Respiratory PRRS Vaccine (PR Newswire)
11.06.18	Eli Lilly To Present New Data From Its Immunology Portfolio - Quick Facts (RTTNews)
11.06.18	Lilly to Unveil New Data at the Annual European Congress of Rheumatology, Furthering Commitment to Scientific Discovery in Immunology (PR Newswire)
05.06.18	Lilly Recommends Shareholders Reject Below-Market Mini-Tender Offer by TRC Capital Corp. (PR Newswire)
05.06.18	DDW 2018: Patients with Moderate-to-Severe Ulcerative Colitis Achieved Clinical and Endoscopic Remission with Mirikizumab in Phase 2 Trial (PR Newswire)
05.06.18	Eli Lilly: FDA Expands ALIMTA Label To Include Combination With KEYTRUD (RTTNews)
05.06.18	FDA Expands Lilly's ALIMTA® (pemetrexed) Label to Include Combination with KEYTRUDA® (pembrolizumab) and Carboplatin as First-Line Treatment for Metastatic Nonsquamous Non-Small Cell Lung Cancer,... (PR Newswire)
04.06.18	FDA Nod For LLY/INCY RA Drug, JAZZ Hits Right Tones, SLS' Study Stopped Early (RTTNews)
01.06.18	FDA Approves OLUMIANT® (baricitinib) 2-mg Tablets for the Treatment of Adults with Moderately-to-Severely Active Rheumatoid Arthritis (PR Newswire)
01.06.18	Lilly to Showcase New Data at Digestive Disease Week 2018 for Mirikizumab in Moderate-to-Severe Ulcerative Colitis (PR Newswire)
31.05.18	Lilly to Participate in Goldman Sachs Global Healthcare Conference (PR Newswire)
30.05.18	Lilly to Participate in Jefferies Global Healthcare Conference (PR Newswire)
23.05.18	Sue Mahony to Retire as President of Lilly Oncology (PR Newswire)
23.05.18	Elanco, Heifer International 10-Year Effort Breaks the Cycle of Hunger for 160,000 Families (PR Newswire)
22.05.18	Eli Lilly: FDA Approves Label Update For Taltz - Quick Facts (RTTNews)
22.05.18	Lilly's Taltz® (ixekizumab) Receives the First U.S. FDA Approval for Label Update to Include Data for Psoriasis Involving the Genital Area (PR Newswire)
18.05.18	AAM to Present at the 2018 Barclays High Yield Bond and Syndicated Loan Conference on May 22 (PR Newswire)
16.05.18	Lilly Data at ASCO Illustrate Patient-Driven Advances in Cancer Care (PR Newswire)
16.05.18	LLY Gets Headache Relief, XENE Abuzz, 3rd Time's A Charm For PFE's Epogen Biosim (RTTNews)
15.05.18	Eli Lilly: Galcanezumab Meets Primary Endpoint In Phase 3 Study - Quick Facts (RTTNews)
15.05.18	Lilly's Galcanezumab Meets Primary Endpoint in Phase 3 Study Evaluating Galcanezumab for the Prevention of Episodic Cluster Headache (PR Newswire)
14.05.18	WeissLaw LLP: ARMO BioSciences Inc. Acquisition May Not Be In The Best Interests of ARMO shareholders (PR Newswire)
14.05.18	Lilly To Buy AurKa Pharma (RTTNews)
14.05.18	Lilly to Acquire AurKa Pharma (PR Newswire)
12.05.18	An Ear To The Pharma: 8 Stocks To Watch (VYGR, BOLD, RXII, CYAD…) (RTTNews)
11.05.18	Lilly to Participate in UBS Global Healthcare Conference (PR Newswire)
10.05.18	Eli Lilly To Acquire ARMO BioSciences For Approx. $1.6 Bln - Quick Facts (RTTNews)
10.05.18	Elanco Animal Health Announces Addition of General Counsel (PR Newswire)
10.05.18	Lilly Announces Agreement To Acquire ARMO BioSciences (PR Newswire)
07.05.18	Lilly Declares Second-Quarter 2018 Dividend (PR Newswire)
01.05.18	Lilly and Local Partners Launch Diabetes Prevention and Management Pilot in Three Underserved Neighborhoods in Indianapolis (PR Newswire)
30.04.18	Leena Gandhi, M.D., Ph.D., to Lead Lilly Oncology Immuno-Oncology Medical Development (PR Newswire)
27.04.18	Lilly to Participate in Bank of America Merrill Lynch Health Care Conference (PR Newswire)
25.04.18	Lilly and China's NCCD announce collaboration to advance scientific understanding and care for people living with diabetes and cardiovascular disease (PR Newswire)
24.04.18	Lilly Q1 Results Beat Estimates; Raises 2018 Outlook (RTTNews)
24.04.18	Eli Lilly And Co. Q1 adjusted earnings Beat Estimates (RTTNews)
24.04.18	Lilly Reports Strong First-Quarter 2018 Results, Raises EPS Guidance (PR Newswire)
24.04.18	AAN 2018: Lilly's Galcanezumab Significantly Reduced Monthly Migraine Headache Days in Patients with Migraine Who Previously Failed to Respond to Multiple Preventive Therapies (PR Newswire)
24.04.18	PRTA Jolted, FDA Strikes Down PFE's Herceptin Biosimilar, No Relief Yet For KMDA (RTTNews)
24.04.18	FDA Panel Backs Lower Dose Of Lilly-Incyte Arthritis Drug, But Not Higher Dose (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

20.12.24		Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone
20.12.24		Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones
20.12.24		Dow Jones aktuell: Dow Jones notiert am Mittag im Plus
20.12.24		Schwacher Handel: SMI schliesst mit Verlusten
20.12.24		Verluste in Europa: Euro STOXX 50 letztendlich leichter
20.12.24		Schwache Performance in New York: S&P 500 notiert zum Handelsstart im Minus
20.12.24		Börse Frankfurt: So steht der LUS-DAX am Nachmittag
20.12.24		Handel in Zürich: SMI verbucht Verluste

20.12.24

Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone

20.12.24

Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones

20.12.24

Dow Jones aktuell: Dow Jones notiert am Mittag im Plus

20.12.24

Schwacher Handel: SMI schliesst mit Verlusten

20.12.24

Verluste in Europa: Euro STOXX 50 letztendlich leichter

20.12.24

Schwache Performance in New York: S&P 500 notiert zum Handelsstart im Minus